In this issue
Drug therapies, delivery systems advance for glaucoma care December 01, 2016By Laird HarrisonPharmacologic products and devices in development continue to gain momentum in the glaucoma treatment armamentarium. Toward emmetropia: More advances, more improvements December 01, 2016By Lynda ChartersAdvances in treatments for keratoconus and presbyopia in 2016 continued to move patients toward emmetropia. Year in review: Cataract surgeryLooking back over the past year and into the near future, Eric D. Donnenfeld, MD, Robert H. Osher, MD, and Mark Packer, MD, spoke to Ophthalmology Times about developments in diagnostic products and other tools used in cataract surgery. In addition, they discussed combination microinvasive glaucoma surgery (MIGS) and office-based surgery as new trends. Approval of a new class of implants tops cataract surgery newsCataract surgeons in the United States have long been envious of the IOL options available to their international colleagues. Finally, in 2016, American ophthalmologists gained access to some novel IOLs such as the Tecnis Symfony Extended Range of Vision IOL and the Tecnis Symfony Toric IOL (Abbott) that were approved by the FDA. According to leading cataract surgeons who spoke to Ophthalmology Times, these simultaneous approvals rank as the biggest cataract surgery news story of the year. MIGS devices lead glaucoma surgical innovation in 2016 December 01, 2016By Laird HarrisonA single event stood out in everyone’s mind when Ophthalmology Times asked experts to think back on the year in glaucoma surgery: the July 29 approval by the U.S. Food and Drug Administration (FDA) of the CyPass Micro-Stent. 2016 Resident Writer's Award Winner: 10 tips for TEN December 15, 2016By Sophia Y. Wang MDA 59-year-old otherwise healthy man presented with an acute-onset diffuse rash involving over 90% of his body surface area, including oral, genital, and ocular mucosal involvement. Initial ophthalmic examination was notable for development of extensive corneal epithelial defects in both eyes as well as conjunctival sloughing and pseudomembrane formation.